ATE133865T1 - Therapeutisches mittel für erkrankungen des zentralnervensystems - Google Patents

Therapeutisches mittel für erkrankungen des zentralnervensystems

Info

Publication number
ATE133865T1
ATE133865T1 AT90312439T AT90312439T ATE133865T1 AT E133865 T1 ATE133865 T1 AT E133865T1 AT 90312439 T AT90312439 T AT 90312439T AT 90312439 T AT90312439 T AT 90312439T AT E133865 T1 ATE133865 T1 AT E133865T1
Authority
AT
Austria
Prior art keywords
diseases
therapeutic agent
nervous system
central nervous
sustained
Prior art date
Application number
AT90312439T
Other languages
English (en)
Inventor
Akinobu Nagaoka
Yasuaki Ogawa
Naohisa Fukuda
Hiroaki Okada
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE133865T1 publication Critical patent/ATE133865T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/066—TRH, thyroliberin, thyrotropin releasing hormone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT90312439T 1989-11-17 1990-11-15 Therapeutisches mittel für erkrankungen des zentralnervensystems ATE133865T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30010889 1989-11-17

Publications (1)

Publication Number Publication Date
ATE133865T1 true ATE133865T1 (de) 1996-02-15

Family

ID=17880816

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90312439T ATE133865T1 (de) 1989-11-17 1990-11-15 Therapeutisches mittel für erkrankungen des zentralnervensystems

Country Status (4)

Country Link
EP (1) EP0429245B1 (de)
AT (1) ATE133865T1 (de)
CA (1) CA2030181A1 (de)
DE (1) DE69025272T2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10025948A1 (de) * 2000-05-26 2001-11-29 Gruenenthal Gmbh Wirkstoffkombination
DE10025949A1 (de) * 2000-05-26 2001-11-29 Gruenenthal Gmbh Arzneimittel zur Bekämpfung von Atemdepression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2146026A (en) * 1983-09-07 1985-04-11 Tanabe Seiyaku Co Peptides and process for preparing the same
IL75641A (en) * 1984-07-10 1990-11-05 Tanabe Seiyaku Co 1-methyl-4,5-dihydro-orotyl-histidyl-prolinamide,its preparation and pharmaceutical compositions comprising it
JP2526589B2 (ja) * 1986-08-08 1996-08-21 武田薬品工業株式会社 ペプチド含有マイクロカプセルおよびその製造法

Also Published As

Publication number Publication date
EP0429245A2 (de) 1991-05-29
DE69025272T2 (de) 1996-06-27
EP0429245B1 (de) 1996-02-07
CA2030181A1 (en) 1991-05-18
DE69025272D1 (de) 1996-03-21
EP0429245A3 (en) 1992-01-15

Similar Documents

Publication Publication Date Title
ATE143263T1 (de) Behandlung von neurodegenerativen erkrankungen
DE59205846D1 (de) Azaheterocyclylmethyl-chromane als Wirkstoffe zur Behandlung von Erkrankungen des Zentralnervensystems
DE69024039D1 (de) Behandlung von pathologischen zuständen und krankheiten.
IT8720698A0 (it) Composizione farmaceutica adattivita' terapeutica per il trattamento della demenza senile di tipo alzheimer.
GB2247837B (en) Pharmaceutical product for the treatment of immunoregulatory disorders
ATE208384T1 (de) Verwendung von ascorbyl-gamma-linolenat und von ascorbyl-dihomo-gamma-linolenat zur behandlung von asthma, krebs, kardiovaskulären und inflammatorischen erkrankungen
GR3032507T3 (en) Human neuronal beta-subunits of voltage-dependent calcium channels and use of the same.
DE3687097D1 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
IL89031A0 (en) Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation
EP0295695A3 (en) New pyrazoline derivatives and agents for treating cerebnew pyrazoline derivatives and agents for treating cerebrovascular diseases containing the same as active ingredrovascular diseases containing the same as active ingredient ient
DE69025272D1 (de) Therapeutisches Mittel für Erkrankungen des Zentralnervensystems
DE3587978D1 (de) Mittel zur Behandlung von Erkrankungen der Venen und des Analbereichs.
EP0457671A3 (en) Dipyridamide for the treatment of diseases of the central or peripheral nervous system
DE68909304D1 (de) Aminosäuren für der Behandung neurodegenerativer Störungen.
EP0427427A3 (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
EA199900862A1 (ru) Способ лечения сосудистых нарушений
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
DE68908445D1 (de) Mittel zur behandlung von lebererkrankungen.
DE68912463D1 (de) Konditionierte insektizide mischungen und verfahren zur insektiziden behandlung.
ATE90565T1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.
DK39584A (da) Anvendelse af nafazatrom til forebyggelse og behandling af diverse sygdomme, laegemidler indeholdende nafazatrom samt fremgangsmaader til disses fremstilling
EP0358160A3 (en) Novel protein having human plasmin inhibiting activity
DE69404370D1 (de) Gelatinase A zur Behandlung von der Alzheimerschen Krankheit
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
CS104088A1 (en) Agent for plants treatment affected by coryneform bacteria

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties